FierceBiotech ١٤ مايو ٢٠٢٦ Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
FierceBiotech ١٤ مايو ٢٠٢٦ Aptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development
FierceBiotech ١٣ مايو ٢٠٢٦ Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities
FierceBiotech ١٣ مايو ٢٠٢٦ Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant
FierceBiotech ١٣ مايو ٢٠٢٦ With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’
FierceBiotech ١٣ مايو ٢٠٢٦ Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
FierceBiotech ١٣ مايو ٢٠٢٦ Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit
FierceBiotech ١٢ مايو ٢٠٢٦ Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
FierceBiotech ١٢ مايو ٢٠٢٦ Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model
FierceBiotech ١٢ مايو ٢٠٢٦ Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset